Actively Recruiting

Age: 18Years +
All Genders
Healthy Volunteers
NCT05273138

Analysis of Dermal Fibroblasts and Immune Cells During Systemic Sclerosis

Led by University Hospital, Lille · Updated on 2025-12-26

40

Participants Needed

1

Research Sites

207 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The pathophysiology of systemic sclerosis (SSc) is still poorly understood and there are no effective treatments for this disease. SSc is a heterogeneous disease with varying severity. The heterogeneity of fibroblast profiles, observed in other fibrosing pathologies, has never been thoroughly explored in the skin of SSc patients. The immune system, and in particular B lymphocytes, plays a central role in the pathophysiology of SSc. The interactions between B lymphocytes and the cells responsible for excess collagen production, i.e. fibroblasts, are not fully elucidated The main objective is to analyze the heterogeneity of fibroblasts and infiltrating immune cells as well as their molecular signature in the skin of patients with SSc

CONDITIONS

Official Title

Analysis of Dermal Fibroblasts and Immune Cells During Systemic Sclerosis

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Man or woman over 18 years of age
  • Diagnosis of systemic sclerosis meeting the ACR-EULAR 2013 criteria
  • Signed informed consent
  • Being insured
Not Eligible

You will not qualify if you...

  • Overlap syndrome with another connective tissue disease according to international criteria
  • Use of immunosuppressive treatment within the last 12 months
  • Current corticosteroid therapy dose of 10 mg/day or higher
  • Protected minors or adults
  • Pregnant or breastfeeding women
  • Deprived of liberty
  • Persons in emergency situations
  • Persons who have refused or are unable to give informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hop Claude Huriez Chu Lille

Lille, France, 59037

Actively Recruiting

Loading map...

Research Team

D

David Launay, MD,PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here